A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.
Pediatric Associates Selects Innovaccer’s AI Platform to Enhance Quality of Care for 1.5 Million Patients
What You Should Know: – Pediatrics Associates, the leading private pediatric primary care group in the US, has partnered with Innovaccer Inc., a leader in
June 7, 2024